Author: Tagliaferri, Ariana R; Narvaneni, Spandana; Azzam, Moh'd Hazem; Grist, William
Title: A Case of COVID-19 Vaccine Causing a Myasthenia Gravis Crisis Cord-id: snbe35ec Document date: 2021_6_10
ID: snbe35ec
Snippet: Myasthenia gravis is a rare disease of the neuromuscular junction subsequently affecting the bulbar, respiratory, and extremity skeletal muscles. It is an autoimmune disease in which antibodies target the acetylcholine receptor (AChR), preventing transmission of the excitatory cascade during muscle contraction. Myasthenia gravis is typically well controlled using acetylcholinesterase inhibitors, steroids, immunosuppressant agents, and/or thymectomies. However, exacerbations can be induced by inf
Document: Myasthenia gravis is a rare disease of the neuromuscular junction subsequently affecting the bulbar, respiratory, and extremity skeletal muscles. It is an autoimmune disease in which antibodies target the acetylcholine receptor (AChR), preventing transmission of the excitatory cascade during muscle contraction. Myasthenia gravis is typically well controlled using acetylcholinesterase inhibitors, steroids, immunosuppressant agents, and/or thymectomies. However, exacerbations can be induced by infection or medications. This is particularly important during the coronavirus disease 2019 (COVID-19) pandemic in which myasthenia gravis patients have been known to have poorer outcomes. We report a very rare presentation of a myasthenia gravis crisis induced by the Moderna COVID-19 vaccine.
Search related documents:
Co phrase search for related documents- acetylcholine receptor and ach release: 1
- acetylcholine receptor and achr acetylcholine receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acetylcholine receptor and activity relationship: 1
- acetylcholine receptor and acute respiratory failure: 1
- action long mechanism and long mechanism: 1, 2, 3
- active covid infection and acute covid infection: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date